Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

NCT00662831 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

DRUG: Fragmin/ Dalteparin Sodium
DRUG: Placebo for Fragmin/ Dalteparin Sodium

Sponsor

Pfizer